oral glp-1 agonist approved List of and pending medications VisualAbstract: Daily Oral GLP-1 Receptor

Although data from early phase trials suggest that retatrutide is well tolerated with a similar adverse event profile to GLP-1 RAs, additional research assessing long-term safety and efficacy of retatrutide in people living with obesity and/or T2D (including cardiovascular outcomes) is awaited over the next five years

Future efforts should address affordability and accessibility through health economic analyses and policy-driven approaches

doi: 10.1016/j.tem.2020.02.006 133 LudwigDSEbbelingCB

Accessed August 11, 2014

Personalized programs like TrimRX offer the medical oversight needed to safely use GLP-1 medications, ensuring you stay on track and address any concerns that may arise

For example, it can tell you how much fat vs